SCHEMBL7243115

SCHEMBL7243115

CNC(=O)c1cccc(NC(=O)COc2cccc(Cl)c2)c1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.68
NOTUM Q6P988 2/20 0.61
MAPT P10636 2/20 0.60
ALDH1A1 P00352 3/20 0.58
LMNA P02545 2/20 0.58
TP53 P04637 1/20 0.55
GAA P10253 1/20 0.55
ALOX12 P18054 1/20 0.55
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
MEN1 O00255 1/20 0.53
POLB P06746 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7237041 0.88 MAPT (0.78) KCNH2MAPTALDH1A1LMNANPC1
SCHEMBL7243165 0.83 MAPT (0.60) KCNH2MAPTALDH1A1LMNANPC1
SCHEMBL7239786 0.81 MEN1 (0.65) KCNH2NOTUMMAPTALDH1A1LMNA
SCHEMBL8428158 0.80 GAA (0.58) NOTUMMAPTALDH1A1LMNATP53
SCHEMBL7240676 0.80 MAPT (0.59) KCNH2NOTUMMAPTALDH1A1LMNA
SCHEMBL7237004 0.79 KDM4E (0.62) KCNH2MAPTALDH1A1TP53NPC1
SCHEMBL4301497 0.78 KCNH2 (0.61) KCNH2MAPTALDH1A1LMNACYP1A2
SCHEMBL18328460 0.77 NOTUM (0.65) KCNH2NOTUMMAPTALDH1A1LMNA
SCHEMBL7238805 0.77 RAB9A (0.78) NOTUMMAPTALDH1A1LMNANPC1
SCHEMBL7244929 0.77 SMN1; SMN2 (0.64) NOTUMMAPTALDH1A1TP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030083523-A1 Amide derivatives MITSUBISHI CHEMICAL CORPORATION (JP) 2003-05-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083523-A1 Amide derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, CBR1 KCNH2 228/4885NOTUM 2512/4885MAPT 3965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.